Document is current
Any future updates will be listed below
-
Authors
Kocatürk, Emek http://orcid.org/0000-0003-2801-0959
Başkan, Emel Bülbül http://orcid.org/0000-0002-0144-3263
Küçük, Özlem Su http://orcid.org/0000-0002-6195-011X
Özdemir, Mustafa http://orcid.org/0000-0002-7022-913X
Örnek, Sinem http://orcid.org/0000-0002-1536-6035
Can, Pelin Kuteyla http://orcid.org/0000-0002-9124-5817
Haşal, Eda http://orcid.org/0000-0001-6310-5107
Engin, Burhan http://orcid.org/0000-0002-5140-1926
Atakan, Nilgün http://orcid.org/0000-0003-3700-514X
Alpsoy, Erkan http://orcid.org/0000-0001-7049-0170
- License Information
-
More Information
This article is maintained by: Elsevier
Article Title: Omalizumab versus cyclosporin-A for the treatment of chronic spontaneous urticaria: can we define better-responding endotypes?
Journal Title: Anais Brasileiros de Dermatologia
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.abd.2022.03.003
Content Type: article
Copyright: © 2022 Published by Elsevier España, S.L.U. on behalf of Sociedade Brasileira de Dermatologia.
